The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...
The final, formatted version of the article will be published soon. Background: The prognosis of patients with primary lung cancer remains poor. Therefore, this study aimed to develop and validate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback